CXCL10 has been shown to aggravate experimental atherosclerosis,24 and to be an independent prognostic factor for increased CVD risk in humans,25 providing a potential mechanism through which BAFF modulates atherosclerotic risk. This evidence concerns the gene TNFSF13B and atherosclerosis.